Gene · 5648
Papers2,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of the immune-related biomarkers in Behcet's disease by plasma proteomic analysis. | Arthritis Res Ther | 2023 | 37264476 | PubTator, text mining | PubMed |
| Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease. | Int J Mol Sci | 2023 | 37240105 | PubTator, text mining | PubMed |
| Plasma Proteomic Analysis Reveals the Potential Role of Lectin and Alternative Complement Pathways in IgA Vasculitis Pathogenesis. | Diagnostics (Basel) | 2023 | 37238213 | PubTator, text mining | PubMed |
| Association between mannose binding lectin gene polymorphisms and clinical severity of COVID-19 in children. | Mol Biol Rep | 2023 | 37231213 | PubTator, text mining | PubMed |
| Integration analysis of miRNA-mRNA expression exploring their potential roles in intrahepatic cholangiocarcinoma. | Sci Rep | 2023 | 37225858 | PubTator, text mining | PubMed |
| Complement: Functions, location and implications. | Immunology | 2023 | 37222083 | PubTator, text mining | PubMed |
| Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases. | J Nanobiotechnology | 2023 | 37221595 | PubTator, text mining | PubMed |
| Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers. | Front Immunol | 2023 | 37205098 | PubTator, text mining | PubMed |
| Mannose-binding lectin gene 2 variant DD (rs 5030737) is associated with susceptibility to COVID-19 infection in the urban population of Patna City (India). | Mol Genet Genomics | 2023 | 37204457 | PubTator, text mining | PubMed |
| Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know. | Immunobiology | 2023 | 37187043 | PubTator, text mining | PubMed |
| Novel Filamin C Myofibrillar Myopathy Variants Cause Different Pathomechanisms and Alterations in Protein Quality Systems. | Cells | 2023 | 37174721 | PubTator, text mining | PubMed |
| Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents. | Cancers (Basel) | 2023 | 37174088 | PubTator, text mining | PubMed |
| The serum proteome of VA-ECMO patients changes over time and allows differentiation of survivors and non-survivors: an observational study. | J Transl Med | 2023 | 37173738 | PubTator, text mining | PubMed |
| Metagenomic next-generation sequencing and proteomics analysis in pediatric viral encephalitis and meningitis. | Front Cell Infect Microbiol | 2023 | 37153144 | PubTator, text mining | PubMed |
| Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer. | Proteomics Clin Appl | 2023 | 37147936 | PubTator, text mining | PubMed |
| Mass Spectrometry of RNA-Binding Proteins during Liquid-Liquid Phase Separation Reveals Distinct Assembly Mechanisms and Droplet Architectures. | J Am Chem Soc | 2023 | 37145883 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the fragility of male spermatogenic cells to Zika virus-induced complement activation. | Nat Commun | 2023 | 37120617 | PubTator, text mining | PubMed |
| Targeted MRM Quantification of Urinary Proteins in Chronic Kidney Disease Caused by Glomerulopathies. | Molecules | 2023 | 37110557 | PubTator, text mining | PubMed |
| Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. | BMC Genomics | 2023 | 37106442 | PubTator, text mining | PubMed |
| Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction. | Nat Commun | 2023 | 37105991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5648/papers?page=12